Ethicon Endo-Surgery Inc. (Ethicon), part of the Johnson & Johnson family of companies, is taking a new angle in the advancement of energy tools for laparoscopic surgery with a first-of-its-kind, articulating energy device that enables stronger vessel sealing and improved tissue access when operating in deep or confined spaces. The company received US Food and Drug Administration 510(k) clearance in February for the ENSEAL G2 Articulating Tissue Sealer, a bipolar energy device that allows surgeons to take a perpendicular approach to seal vessels up to 7 mm in diameter through a 5-mm port. The company plans to launch the device in the next six months.
According to Tom O’Brien, Ethicon’s VP of global strategic marketing, surgeons prefer a perpendicular approach when sealing vessels during laparoscopic...